Stem Cells and the Rate of Living  by Krishnamurthy, Janakiraman & Sharpless, Norman E.
Cell Stem Cell
PreviewsStem Cells and the Rate of Living
Janakiraman Krishnamurthy1 and Norman E. Sharpless1,*
1Departments of Medicine and Genetics, The Lineberger Comprehensive Cancer Center, The University of North Carolina School
of Medicine, Chapel Hill, NC 27599, USA
*Correspondence: nes@med.unc.edu
DOI 10.1016/j.stem.2007.05.004
The ‘‘rate-of-living theory’’ is an ancient explanation of longevity which holds that aging occurs due to
the exhaustion of some finite substance—breaths, heartbeats, etc. While this theory as originally
conceived has been debunked, new work (Ruzankina et al. [2007], in this issue of Cell Stem Cell)
suggests that mammals in fact do have a finite number of stem cell replications per life.Most mammalian organs are in part
composed of cells that have a finite
lifespan but which are constantly
replenished from a source of stem
andother self-renewing compartments.
As we grow old, our stem cells appear
to lose replicative capacity, and this in
turn causes some aspects of aging
(reviewed in Sharpless and DePinho
[2004]), but it is not precisely known
what causes this decline in regenera-
tive potential. Provocative hints have
come from the observation that hu-
mans and mice with congenital defi-
ciencies of DNA repair and metabo-
lism exhibit premature stem cell
dysfunction (Prasher et al., 2005) and
features of accelerated aging (de
Boer et al., 2002; Vogel et al., 1999).
Likewise, exposure to DNA-damaging
agents such as chemo- and radiother-
apy induces some aspects of aging
also in the setting of a durable degra-
dation of stem cell function (Knudsen
et al., 1999; Testa et al., 1985; Wang
et al., 2006). A problem from these
lines of evidence, however, is that
DNA damage affects all cells in these
models, including rapidly proliferating
progeny that lack self-renewal capac-
ity but which are crucial to organismal
homeostasis. Depletion of these prog-
eny, for example after a sublethal dose
of radiotherapy, forces an immense
replicative cost on the remaining
stem cells, which have to divide in
order to regenerate depleted progeni-
tors. Therefore, one cannot tell from
these observations whether the de-
cline in stem cell function results from
DNA-damaging events within stem
cell compartments themselves or
whether the stress of forced and re-
peated proliferation leads to exhaus-tion of self-renewing cells. While
many of us would have guessed that
intrinsic DNA damage is the lesion in
old stem cells, an intriguing new study
from Ruzankina et al. (2007) addition-
ally suggests that replication itself
comes with some cost to the self-
renewing compartments.
The authors took a very clever
approach to get at this question. Using
a conditionally inactivatable allele, the
authors excised the ataxia-telangecta-
sia and Rad3-related (ATR) gene in
a wide variety of adult murine tissues
through transient somatic activation
of a tamoxifen (TAM)-inducible Cre re-
combinase. ATR is a PI3K-like kinase
that activates multiple downstream
signaling networks in response to
DNA damage, particularly DNA repli-
cation intermediates such as stalled
replication forks. Prior work had dem-
onstrated that ATR deficiency is highly
toxic to replicating cells (Brown and
Baltimore, 2000), and therefore it is
not surprising that acute somatic ATR
deletion induced rapid depletion of
proliferating cells in tissues such as
the bone marrow and intestine. Con-
sistent with the experience of others,
Cre-mediated excision was not 100%
efficient, and TAM-treated mice
quickly repopulated these proliferative
tissues through the replication of ATR
nonrecombined (i.e., functional) cells.
Just as is the case after a large dose
of sublethal radiation, for all intents,
these reconstituted mice appeared
normal by 1 month post-TAM. Gratify-
ingly, largely quiescent tissues (e.g.,
brain) in TAM-treated mice retained
ATR-deficient cells, yet the animals
developed little or no phenotypic ef-
fects of this, suggesting the principalCell Stefunctions of ATR are related to cell
division.
While these observations are impor-
tant for those interested in DNA repair
and ATR, we believe the finding that
will be of greatest general scientific in-
terest is what happened next. While
TAM-treated mice rapidly reconsti-
tuted missing proliferative cells, this
episode of forced regeneration ap-
pears to come at some durable cost.
By 3 months after treatment, the
TAM-exposed mice developed a care-
fully detailed, widespread, and im-
pressive progeroid phenotype includ-
ing graying, osteopenia, changes in
skin thickness, and loss of hematopoi-
etic and lymphoid progenitors. Im-
portantly, the authors show that
these phenotypes occur in tissues in
which virtually all the cells harbor the
unrecombined (intact) ATR allele. This
finding indicates that the accelerated
aging occurs in ATR-competent tis-
sues and therefore is the result of
forced regeneration rather than ATR
deficiency. The authors offer evidence
that the obligate tissue regeneration
leads to stem cell exhaustion in a few
compartments, contributing to the
aging phenotypes observed. While re-
lated results have been reported after
regeneration induced by the use of
noxious agents (e.g., IR, chemother-
apy), the major strength of this genetic
approach is that it illustrates that cellu-
lar depletion can act in an extrinsic
manner to induce aging. That is, stem
cell exhaustion can occur as a result
of proliferative stress forced through
normal homeostatic mechanisms.
There are several advantages to this
experimental approach: the pheno-
type is seen in ATR competent cells,m Cell 1, July 2007 ª2007 Elsevier Inc. 9
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Stem cells have the capacity to self renew (light blue arrow) and asymmetrically divide to produce progenitor cells, which in turn give rise to dif-
ferentiated cellular components. With physiologic aging, stem cell quality, but not necessarily quantity, declines (shownwith a hatched outline). Acute
somatic ATR excision is cell-autonomously lethal to proliferating cells and is followed by tissue reconstitution as a result of the replication of
ATR-competent stem cells. Enforced regeneration, however, accelerates aging in many tissues, presumably because of a ‘‘premature aging’’ of
the stem cell compartments.there is no issue of toxicity from Cre
recombinase expression, there is no
need for extrinsic DNA-damaging
agents, etc. However, as the authors
note, the results come with a signifi-
cant experimental caveat: this study
does not tell us in which ATR-compe-
tent cells the aging actually occurs.
We presume the cost of forced regen-
eration is greatest in self-renewing
compartments (e.g., Figure 1), but
because the Cre allele is expressed
ubiquitously, it is possible that forced
regeneration could be toxic to other
compartments as well, or even in-
stead. For example, while we favor
the model that somatic excision of
ATR in the skin causes premature10 Cell Stem Cell 1, July 2007 ª2007 Elsgraying because forced regeneration
exhausts melanocytic stem cells, this
interpretation has not been explicitly
shown. In fact, the stem cell ‘‘niche’’
in other systems has been demon-
strated to play an important role in
determining stem cell function with
age (Conboy et al., 2005). Therefore,
as the authors point out, it is possible
that ATR excision and subsequent
regeneration somehow damage the
niche rather than the self-renewing
cells within. Delineating the effects of
forced regeneration on supporting
cells such as those comprising the
niche versus the stem cells themselves
will be an important question for future
study.evier Inc.In summary, these new data (Ru-
zankina et al., 2007) suggest that
maybe there is something to this
rate-of-living hypothesis after all.
While there clearly is no finite number
of heart beats per human life span,
there may be a limit to how many
times a stem cell can divide. The mo-
lecular nature of the barrier that limits
total number of stem cell prolifera-
tions (or ‘‘the replicometer,’’ in Hay-
flickean parlance) is not known, but
it is not likely to be telomere based
in these experiments using inbred
rodents harboring ample telomeric re-
serve (Sharpless and DePinho, 2004).
An alternative model is that the barrier
is stochastic in nature: perhaps there
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sion of a disaster of replication that
leads to a dysfunctional, but not
dead, stem cell. In this model, with
time these damaged stem cells accu-
mulate, and eventually with aging,
tissue regeneration is compromised
as a result of their reduced function.
If correct, this model has implications
for regenerative medicine-based
approaches for aging therapy: if cell
division itself is toxic to adult, tissue-
specific stem cells, from where will
we make new ones when we grow
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The lung is a complex solid tissue that
has eluded stem cell biologists for
many years. Lung injury modeling in
rodents has suggested that adult lung
stem or progenitor cells exist, yet there
has been a paucity of lineage relation-
ship analysis in the pulmonary system
and little demonstration that lung cells
exhibit stem cell properties (recently
reviewed by Rawlins and Hogan
[2006]). The limited number of molecu-
lar markers for lung cells and previous
work assigning stem/progenitor cell
function without detailed analyses of
self-renewal or differentiation are key
factors which have precluded an un-
derstanding of stem cell identity in
the lung and knowledge of the
pathways required for adult lung
homeostasis.REFERENCES
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Ventura and colleagues have now
reported the isolation of a putative
stem or progenitor cell population
from the adult lung and show that the
fate of these cells is altered by
MAPK14 deletion (Ventura et al.,
2007). Mice bearing a conditional null
allele of Mapk14 were mated to mice
with large subunit RNA polymerase
II-driven Cre-ERT2 mice (RERTnERT).
Despite Cre-mediated recombination
in diverse tissues after systemic
tamoxifen treatment, the most promi-
nent phenotype was a severe disrup-
tion of pulmonary morphology with
amarked increase in cycling lung cells,
more numerous SP-C+ cells, and a
decrease in E-cadherin-positive cells
that were collectively interpreted
as lung differentiation defects.
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